TLVSN --Is a Labyrinthectomy Enough?

Transmastoid Labyrinthectomy Versus Translabyrinthine Vestibular Nerve Section: Does Cutting the Vestibular Nerve Make a Difference in Outcome?
De La Cruz A, Teufert KB, Berliner KI:
Otol Neurotol 2007; 28 (September): [801] [802] [803] [804] [805] [806] [807] [808] Labyrinthectomy and translabyrinthine vestibular nerve section have similar rates of vertigo control and postoperative imbalance.
Classic Article Review -Background: Labyrinthectomy typically has a very high success rate at controlling vertigo in Ménière's disease patients. This procedure is also sometimes combined with a vestibular nerve section. William House popularized the translabyrinthine vestibular nerve section (TLVNS) in the 1950s as the gold standard for vestibular ablation surgery. The labyrinthectomy is a slightly simpler procedure that may leave residual vestibular tissue around Scarpa's ganglion, which may form a source of neuroma formation or persistent vertigo.
Objective: To determine if TLVNS and labyrinthectomy offer similar outcomes. Design: Patient survey. Participants: 135 patients underwent either a labyrinthectomy or TLVNS surgery for vertigo between 1990 and 2005 and were sent a survey; 42 responded.
Methods:
The questionnaire asked patients to rate their symptoms using the American Academy of Otolaryngology-Head and Neck Surgery criteria. Questions covered frequency, severity, and degree of interference with everyday activities. The same rating scales were used for current symptoms and symptoms prior to surgery. Patients were also asked if they had any subsequent surgery for vertigo control.
Results:
Patients who underwent labyrinthectomy were significantly older at the time of surgery, with a mean age of 59 years versus 45 years in TLVNS patients. Follow-up was 4.5 years for labyrinthectomy and 7.8 years for TLVNS. About 64% of patients had a Ménière's diagnosis. Other diagnoses included fistula, vestibular hydrops, vestibular neuronitis, sudden sensorineural hearing loss, or posttraumatic vertigo. Both groups had a similar number of reported vertigo spells prior to surgery. Both groups reported vertigo, and disability scores were improved from preoperative levels. In both groups, 24% said they continued to experience vertigo. More than 80% of both groups indicated that they continued to experience imbalance; however, in the labyrinthectomy group, 46% indicated their balance had improved after surgery compared with 81% in the TLVNS group. Vertigo was minor or resolved in about 80% of both groups, and a single digit percentage of both groups rated their current vertigo symptoms as severe. Conclusions: Labyrinthectomy and TLVNS offer similar success rates for vertigo control. Reviewer's Comments: Interestingly, only 64% of patients had a Ménière's diagnosis. Other diagnoses such as sudden sensorineural hearing loss do not seem an appropriate indication for a labyrinthectomy. There is a significant amount of clinical information missing in these patients that may have contributed to their vertigo and imbalance. Patients were asked to rate their preoperative symptoms several years after surgery, so significant recall bias is possible. The main significant difference was that patients undergoing TLVNS had a greater decrease in imbalance after surgery than did labyrinthectomy patients. This is difficult to interpret because these groups were not similar; labyrinthectomy patients were 14 years older at surgery and had a shorter follow-up. (Reviewer-Benjamin T. Crane, MD). 
First Case Series of PCD
Participants:
The study included 12 patients ranging in age from 2 to 67 years (including 7 pediatric patients).
Patients were found to have PCD on CT scan and reduced VEMP thresholds and increased amplitude. Methods: CT scans were performed with 1-mm slices and standard axial and coronal reconstructions. Audiometry was also performed in all but 1 individual. Cervical VEMPs were performed in post-PCD patients.
Results: 1 patient was found to have bilateral PCD. One patient had an iatrogenic dehiscence caused by surgery. Seven patients were aged <8 years, making their symptoms difficult to assess. However, all adult patients had aural fullness. Only 1 patient had vertigo with sound, and 4 reported dysequilibrium. Most patients had a mixed hearing loss, with negative bone conduction thresholds present in 2. In 70% of noniatrogenic cases, the dehiscence was identified into a high-riding jugular bulb on the caudal portion of the posterior canal. In the remaining 3 cases, the dehiscence was into the posterior cranial fossa. Two patients also had evidence of superior canal dehiscence. It is interesting that all but 1 of the noniatrogenic cases occurred on the right side. This may be due to the right dominant jugular vein drainage in most people. Conclusions: This is the largest series of PCD to date. Most patients had conductive hearing loss. Noniatrogenic dehiscences tended to open into the jugular bulb. Reviewer's Comments: This paper represents a significant advance in the understanding of PCD, but it will not likely be the last word on the subject. One issue with a diagnosis of superior canal dehiscence is that CT can be misleading by over-diagnosing dehiscence. Although most cases were confirmed by VEMP and lowfrequency conductive hearing loss, stronger evidence of the posterior origin would have been nystagmus in the posterior canal plane caused by stimulation of the affected ear with noise or pressure. Furthermore, none of the PCDs were directly observed or treated. It is unclear if treating this problem would address patient symptoms. More than half of these PCD cases occurred in children, in contrast to superior canal dehiscence, which is almost always acquired in adulthood. (Reviewer-Benjamin T. Crane, MD). Survey, 2001 Survey, -2004 . People who have dizziness and vestibular dysfunction on testing have a 12-fold increase in the risk of falling.
Vestibular Disorders May Be Common Cause of Falls
Disorders of Balance and Vestibular Function in US Adults: Data From the National Health and Nutrition Examination
Background: Dysfunction of the vestibular system is a disorder that we, as otolaryngologists, commonly encounter. Vestibular dysfunction can be the underlying cause of falls, which is a considerable source of morbidity in the elderly population. Sequelae from these events are a common cause of death in this population. The exact magnitude of this problem has been difficult to estimate, and the relationship between vestibular dysfunction and falls in the general population has previously been difficult to determine. Objective: To analyze the National Health and Nutrition Examination Survey (NHANES) to determine the relationship between falls and vestibular dysfunction. Design: Analysis of cross-sectional survey results. Participants: 5086 American adults aged ≥40 years who participated in the NHANES survey were included. Individuals were excluded for conditions such as severe visual impairment, inability to stand, or weight >275 pounds. Methods: Patients were given a balance questionnaire that asked about dizziness, balance, and history of falls. The balance testing consisted of a modified Romberg Test of standing on firm and compliant surfaces. Subjects were asked to stand unassisted using 4 test conditions. The 4th condition was designed to assess the vestibular system-standing on a foam pad with eyes closed. The test was scored on a pass-fail basis. Failing occurred if subjects opened their eyes, moved their arms or feet to maintain stability, or began to fall. Results: As determined by failure of test condition 4, 35.4% of subjects had vestibular dysfunction. The rate of dysfunction was higher with advancing age, less than a high school education, greater smoking history, and a history of hypertension, diabetes, and falls. Because there was a significant association between vestibular dysfunction and several other variables, the association between vestibular dysfunction and falls was reanalyzed after adjusting for age, gender, race, and cardiovascular risk factors. Subjects who had dizziness and vestibular dysfunction on testing had a 12-fold increase in the risk of falling. Bevacizumab may reduce the tumor burden in neurofibromatosis type 2 patients with vestibular schwannomas and improve hearing in some patients.
Background: Unlike treatment for sporadic vestibular schwannoma, surgical and radiotherapy treatments for vestibular schwannoma among patients with neurofibromatosis type 2 (NF2) do not compare well to the sporadic types. Pathologically, schwannoma is not technically a vascular lesion, but angiogenesis has been noted to be important for its growth. Objective: To determine if bevacizumab, a monoclonal antibody that specifically antagonizes vascular endothelial growth factor (VEGF) pathway, can be used to treat vestibular schwannomas. Design/Methods: Retrospective study of records of 10 patients with NF2 with vestibular schwannomas who were treated with bevacizumab. Prior to this, the authors presented their study of immunostaining of vestibular schwannomas from NF2 patients. They looked at expression of VEGF and other factors that are important in the VEGF signaling pathway. Patients were followed up radiographically with MRI as well as audiograms. Included in the study were those with NF2 with progressive disease who were not amenable to surgery or radiotherapy. Patients were followed up clinically with MRI and serial audiograms before and after use of bevacizumab. Toxicity profiles were also followed. Responses were defined as >20% reduction in tumor volume as dictated by MRI. Hearing responses were defined as improvements in word recognitions score compared to baseline.
Results:
In terms of immunostaining, VEGF was expressed in 100% of specimens. Moreover, one of the receptors for VEGF, VEGFR-2, was expressed in 32% of the tumor vasculature. In terms of the clinical trial, 9 of 10 patients showed radiographic evidence of tumor shrinkage. Of 10 patients, 7 were eligible for audiological studies after treatment; 4 of these patients had a hearing response according to word recognition scores. In terms of side effects, bevacizumab treatment resulted in 21 adverse events of grade 1 or 2. Conclusions: Bevacizumab can modestly reduce the volume of the tumor in most patients with NF2. In some patients, there are improvements of hearing with sustained improvement for up to 16 months. Reviewer's Comments: This was an interesting study for several reasons. One is the finding that hearing loss can be reversed in some patients treated with bevacizumab. All patients with improvements in hearing or stable hearing had volume reduction of tumor. The authors posit that the hearing improvement is likely correlated with intraneural edema and tumor shrinkage, but not all patients who had volumetric response had hearing improvements. This suggests that there may a window of opportunity to reverse the hearing loss due to schwannomas. The other interesting finding, of course, is that these schwannoma lesions can be treated with biological reagents that target VEGF pathways. (Reviewer-Young J. Kim, MD).
Forehead Flap Complications Increased in Smokers With Full-Thickness Defects
Complications With Forehead Flaps In Nasal Reconstruction. Full-thickness defects and smoking are associated with an increased risk of forehead flap complications.
Objectives:
To identify clinical characteristics associated with forehead flap failures in patients undergoing reconstruction for nasal defects. Design/Participants: Retrospective chart review on all patients (n=205) who underwent forehead flap reconstruction for nasal defects by the senior author over a 13-year period. Methods: A minimum of 4 months of follow-up was an inclusion criterion. Presence or absence of diabetes, smoking, and vascular disease was documented. Use of crushed autologous cartilage combined with Tutoplast-processed fascia lata offers another viable technique in achieving nasal dorsum augmentation in appropriate candidates.
Background: Autologous cartilage is considered the ideal material for nasal dorsum augmentation, given its unsurpassed biocompatibility and ease to carve. However, limited cartilage availability, donor-site morbidity, and concern for visible cartilage graft contour secondary to warping are all potential concerns. Objective: To examine the outcome of dorsal augmentation with crushed cartilage layered with Tutoplastprocessed fascia lata (TPFL). Design/Participants: Retrospective chart review conducted on a series of 113 patients who underwent dorsal augmentation with crushed cartilage combined with TPFL. Methods: The crushed cartilage was placed underneath 2 to 3 layers of TPFL, which was placed underneath the soft tissue envelope. Outcome measures included subjective evaluation of patient satisfaction and documented incidence of complications. The follow-up period ranged from 8 to 38 months, with a mean followup of 27 months. Results: Various types of grafts were used in combination with TPFL in the study, including septal cartilage, costal cartilage, conchal cartilage, and ethmoid bone. Among 101 patients who responded to the questionnaire, 85% were reported to be satisfied with the esthetic outcome. A 3.5% complication rate is reported in the study, including over-augmentation of the nasal dorsum, graft resorption, and complaint of dorsal irregularity. Revision rhinoplasty was performed in 8 patients (7.1%) for nasal tip revision, graft resorption, and over-augmentation of the nasal dorsum.
Conclusions:
Crushed autologous cartilage cushioned with TPFL offers a viable alternative nasal dorsum augmentation and contouring in appropriate candidates. Reviewer's Comments: The search for the most suitable dorsal augmentation material continues. While autologous cartilage material has been widely considered to be the gold standard, limitations, such as associated donor-site morbidity and amount of graft available, need to be considered. Use of TPFL combined with crushed cartilage offers another viable method for augmenting the nasal dorsum, such as the Turkish delight (diced cartilage wrapped in Surgicel). However, as the authors pointed out, use of this technique has its limitations, including the cost of TPFL and unpredictable resorption. Again, appropriate selection of appropriate candidates is critical. (Reviewer-Tang Ho, MD).
